Prelude Therapeutics Stock Options
| PRLD Stock | USD 0.84 0.03 3.70% |
Prelude Therapeutics' latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 2.13. The Prelude Therapeutics option chain provides detailed quote and price information for the current Prelude Therapeutics option contracts. It shows all of Prelude Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Prelude Therapeutics
Analyzing Prelude Therapeutics' in-the-money options over time can help investors to take a profitable long position in Prelude Therapeutics regardless of its overall volatility. This is especially true when Prelude Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Prelude Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Prelude Therapeutics' stock while costing only a fraction of its price.
Prelude Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Prelude Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Prelude stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Prelude Therapeutics' stock price goes up or down, the stock options follow.
At present, Prelude Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. Prelude Current Options Market Mood
Prelude Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Prelude Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Prelude Therapeutics' options investors are not very successful. Prelude Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Prelude contract
Base on the Rule 16, the options market is currently suggesting that Prelude Therapeutics will have an average daily up or down price movement of about 0.13% per day over the life of the 2025-09-19 option contract. With Prelude Therapeutics trading at USD 0.84, that is roughly USD 0.001118. If you think that the market is fully incorporating Prelude Therapeutics' daily price movement you should consider buying Prelude Therapeutics options at the current volatility level of 2.13%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Prelude Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Prelude calls. Remember, the seller must deliver Prelude Therapeutics stock to the call owner when a call is exercised.
Prelude Therapeutics Option Chain
When Prelude Therapeutics' strike price is surpassing the current stock price, the option contract against Prelude Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Prelude Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Prelude. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Prelude. It also shows strike prices and maturity days for a Prelude Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | PRLD250919C00007500 | 56 | 7.5 | 0.0 - 0.05 | 0.05 | Out |
Call | PRLD250919C00005000 | 0 | 5.0 | 0.0 - 4.6 | 4.6 | |
Call | PRLD250919C00002500 | 5 | 2.5 | 0.0 - 0.5 | 0.1 | Out |
Put | PRLD250919P00007500 | 0 | 7.5 | 4.3 - 8.8 | 4.3 | In |
Put | PRLD250919P00005000 | 0 | 5.0 | 1.8 - 5.9 | 1.8 | In |
Put | PRLD250919P00002500 | 0 | 2.5 | 0.0 - 4.7 | 4.7 | In |
Prelude Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Prelude Total Stockholder Equity
Total Stockholder Equity |
|
Prelude Therapeutics Corporate Management
| WanJen MD | Senior Development | Profile | |
| Laurent MBA | Chief Officer | Profile | |
| William MD | Senior Development | Profile | |
| Naveen Babbar | Senior Medicine | Profile | |
| Neelesh MD | VP Devel | Profile | |
| Aimee Crombie | Senior Operations | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prelude Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Prelude Stock refer to our How to Trade Prelude Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prelude Therapeutics. If investors know Prelude will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prelude Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Prelude Therapeutics is measured differently than its book value, which is the value of Prelude that is recorded on the company's balance sheet. Investors also form their own opinion of Prelude Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Prelude Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prelude Therapeutics' market value can be influenced by many factors that don't directly affect Prelude Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prelude Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Prelude Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prelude Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.